Tech Reporter Virgin Islands
SEE OTHER BRANDS

The latest science and technology news from the U.S. Virgin Islands

Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on April 11, 2025

Louis Limited Introduces AI-Powered Financial Insights for Global Market

Louis Limited Introduces AI-Powered Financial Insights for Global Market

Louis Limited launches an AI-powered trading app globally that tracks traders' emotional responses to market fluctuations. Founded in Malaysia in 2019, the company expands from serving 6,000 local clients through its platform that offers behavioral …

Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

MONTREAL, April 11, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, wishes to address its shareholders in response to a press release issued …

Theratechnologies réagit à la récente déclaration publique de Future Pak et annonce des discussions exclusives avec un autre acquéreur potentiel pour la vente de la Société

Theratechnologies réagit à la récente déclaration publique de Future Pak et annonce des discussions exclusives avec un autre acquéreur potentiel pour la vente de la Société

MONTRÉAL, 11 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, désire s’adresser à ses actionnaires en réponse à un communiqué de …

Signing Day Sports Announces Selected Financial Results for the Year Ended December 31, 2024

Signing Day Sports Announces Selected Financial Results for the Year Ended December 31, 2024

SCOTTSDALE, Ariz., April 11, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, …

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document

DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document

Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical …

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024

Châtillon, France, le 11 avril 2025 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique au stade clinique …

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to its newly appointed …

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“ …

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that on April 8, 2025, …

4DMT Announces New Employment Inducement Grants

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation …

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier …

iOThree Limited Announces Closing of Initial Public Offering

iOThree Limited Announces Closing of Initial Public Offering

SINGAPORE, April 11, 2025 (GLOBE NEWSWIRE) -- iOThree Limited ("iOThree" or the "Company") (NASDAQ: IOTR), a leading provider of maritime digital technologies including satellite connectivity and digitalization solutions in Singapore with a focus on …

Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns

Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns

Board Timed Highly Dilutive Financing to Close on the Record Date for the Annual Meeting, Tilting the Vote and Forcing the Withdrawal of the Restore Value Slate Second Major Transaction in Six Months Undertaken Without Stockholder Input with Significant …

Bel Fuse Schedules First Quarter 2025 Financial Results Conference Call

Bel Fuse Schedules First Quarter 2025 Financial Results Conference Call

WEST ORANGE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a designer, manufacturer, and provider of products that power, protect and connect electronic circuits, today announced plans to release preliminary financial …

Securing the Future: BankSocial® Secura™ Emerges as Web3’s Trusted Enforcement Engine

Securing the Future: BankSocial® Secura™ Emerges as Web3’s Trusted Enforcement Engine

DALLAS, Texas, April 11, 2025 (GLOBE NEWSWIRE) -- As Web3 rapidly evolves, so too do the threats facing consumers and institutions alike. In response, BankSocial® has deepened its commitment to real-time protection and financial recovery through its …

TestoPrime Reviews: Best Testosterone Booster Supplement For Men Over 40 & 50 – Is TestoPrime Tablets Safe?

TestoPrime Reviews: Best Testosterone Booster Supplement For Men Over 40 & 50 – Is TestoPrime Tablets Safe?

GLASGOW, United Kingdom, April 11, 2025 (GLOBE NEWSWIRE) -- There are relatively few testosterone boosters with natural substances that have been clinically shown to increase testosterone levels without producing side effects. Currently, Testoprime is one …

GEEKVAPE Releases Inaugural Sustainability Report, Affirming Its Sustainability Strategy

GEEKVAPE Releases Inaugural Sustainability Report, Affirming Its Sustainability Strategy

Shenzhen, China, April 11, 2025 (GLOBE NEWSWIRE) -- Recently, GEEKVAPE officially released the GEEKVAPE 2024 Sustainability Report (hereinafter referred to as the “Report”), marking the first time the Company has systematically outlined its sustainability …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service